DiscoverWSJ What’s NewsEven as Generic-Drug Approvals Soar, Many Haven't Hit the Market
Even as Generic-Drug Approvals Soar, Many Haven't Hit the Market

Even as Generic-Drug Approvals Soar, Many Haven't Hit the Market

Update: 2019-11-201
Share

Description

A.M. Edition for November 20th: A Wall Street Journal analysis has found that even though more generic drugs are being approved by the Food and Drug Administration, many haven't made it to patients. Jared S. Hopkins explains. Plus, our exclusive interview with exiled Bolivian president Evo Morales. And Rebecca Ballhaus on what to expect in today's impeachment hearings. Kim Gittleson hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments 
loading
Download from Google Play
Download from App Store
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Even as Generic-Drug Approvals Soar, Many Haven't Hit the Market

Even as Generic-Drug Approvals Soar, Many Haven't Hit the Market

The Wall Street Journal